— Know what they know.
Not Investment Advice

EXAI NASDAQ

Exscientia plc
1W: -13.7% 1M: -4.2% 3M: -14.8% 1Y: -16.8% 3Y: -77.2%
$4.84
Last traded 2024-11-20 — delisted
NASDAQ · Healthcare · Biotechnology · $633.2M mcap · 84M float · 0.840% daily turnover

Cash Flow Trends

Operating Cash Flow
-$118M -97.0% ▼
Capital Expenditures
$27M -20.4% ▼
4Y CAGR: +86.0%
Free Cash Flow
-$144M -76.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$145M +6.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$11M-$33M-$56M-$139M-$162M
Depreciation & Amort.$753K$1M$4M$9M$16M
Stock-Based Comp.$932K$2M$8M$25M$24M
Change in Working Capital$19M-$5M$38M$70M-$21M
Other Non-Cash Items$149K$6M-$39K-$27M$31M
Operating Cash Flow$9M-$29M-$5M-$60M-$118M
— Investing Activities —
Capital Expenditures-$2M-$3M-$7M-$22M-$26M
Acquisitions (Net)$0-$2M-$19M-$239K$0
Investment Purchases$0-$2M-$1M-$99M-$2M
Investment Sales$0$0$1M$100M$204M
Other Investing-$172K$2M$7M-$100M-$198M
Investing Cash Flow-$2M-$5M-$20M-$121M-$22M
— Financing Activities —
Net Debt Issuance-$162K-$470K-$881K-$2M-$3M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$16K$0$0-$2M-$243K
Financing Cash Flow-$191K$77M$395M-$4M-$3M
Net Change in Cash$7M$42M$500M-$155M-$145M
Cash End of Period$41M$85M$562M$399M$259M
Free Cash Flow$7M-$32M-$12M-$82M-$144M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms